A Phase 1, Open-Label Study, Investigating First-Dose and Steady-State Pharmacokinetics of Raltegravir in the Genital Tract of HIV Uninfected Women.
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 02 Mar 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2008 New trial record.